Senate Bill 1466 Summary

• Expands medical marijuana definitions to include autism spectrum disorder and post-traumatic stress disorder as debilitating medical conditions, and allows physician certifications via telehealth instead of only in-person visits.

• Establishes packaging and labeling requirements for marijuana products including QR codes linking to harvest dates, THC strain information, test results, and poison control warnings; prohibits packaging resembling children's products or brands.

• Creates a tracking system requirement for nonprofits and establishments to monitor marijuana cultivation, processing, and sales; requires proficiency testing for laboratories by contracting with commercially available providers.

• Authorizes delivery of marijuana by establishments under regulated rules starting January 1, 2023, with requirements for GPS tracking, video surveillance, locked compartments, and age verification.

• Increases funding for marijuana clinical trials from $5 million to $10 million annually and allows interchangeable use of medical marijuana and adult-use marijuana funds for implementation and enforcement of both programs.